Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice
XF-iMSCs are promising candidates for promoting muscle regeneration while avoiding fibrosis, offering a safer and more effective therapeutic approach for UCMD than other potential therapies.
Authors
- Souta Motoike (ORCID: https://orcid.org/0009-0003-2413-0280)
- Junya Toguchida (ORCID: https://orcid.org/0000-0002-0184-9685)
- Chengzhu Zhao (ORCID: https://orcid.org/0000-0001-7957-5381)
- Yoshiko Inada
- Clémence Kiho Bourgeois Yoshioka
- Hidetoshi Sakurai (ORCID: https://orcid.org/0000-0002-5383-9366)
- Makoto Ikeya (ORCID: https://orcid.org/0000-0002-3930-8032)
- Denise Zujur (ORCID: https://orcid.org/0000-0002-7696-1065)
- Nana Takenaka-Ninagawa
- William Theoputra
- Yonghui Jin
- Megumi Yokomizo-Goto
- M Miki
Institutions
- Kyoto University (JP)
- Nagoya City University (JP)
- Kyoto University Hospital (JP)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2024-10-06
- DOI
- https://doi.org/10.1186/s13287-024-03951-6
- Citations
- 5
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 2.19
Funders
- Japan Agency for Medical Research and Development
- Research Center Network for Realization of Regenerative Medicine
- Japan Society for the Promotion of Science